Trading Signals: REGN Stock Price Prediction and Forecast (Fri. Mar. 14, 2014 - Fri. Dec. 22, 2023)(Regeneron Pharmaceuticals Inc)
| REGN latest price $406.3600 (-3.04%) ($404.5950 - $421.7700) on Thu. Sep. 29, 2016. | |
| | Trend Analysis and Forecast | | | Average Daily Percentage Swing | 1.84% (three month average) | RSI | 64 | Latest Price | $406.3600(-3.04%) | Stocks Behave Similarly | Similar Stock List | Daily Trend | REGN declines -0.1% a day on average for past five trading days. | Weekly Trend | REGN advances 2.1% a week on average for past two weeks. | Market Behavior | Broad based sell-off for large cap. Broad based sell-off for small cap. | Correlated ETFs | Broad market will support REGN advance at 0% a week (0% probability) IBB(62%) XLV(50%) XBI(45%) IVW(40%) IWF(40%) | Factors Impacting REGN price | REGN will decline at least -0.92% in a week (0% probabilities). VIXM(-9%) TLT(-8%) UUP(-7%) TIP(-3%) SHY(-3%) | | | | | Relative Volatility | (options are extremely cheap) | | | Market Trend Strength | -0.92% (StdDev 1.84%) | Hourly BBV | 0 () | Intraday Trend | -3% | | | |
|
5 Day Moving Average | $412.28(-1.44%) | 10 Day Moving Average | $409.55(-0.78%) | 20 Day Moving Average | $403(0.83%) | To recent high | -7.9% | To recent low | 16.8% | Market Cap | $43.086b | | | | Regeneron Pharmaceuticals, Inc. is a biotechnology company, which engages in the discovery, invention, development, manufacture, and commercialization of medicines. It product portfolio includes the following brands: EYLEA, Dupixent, Praluent, Kevzara, Libtayo, ARCALYST, and ZALTRAP. The company was founded by Alferd G. Gilman, Leonard S. Schleifer, and Eric M. Shooter on January 8, 1988 and is headquartered in Tarrytown, NY. |